Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial
- Author(s)
- 강윤구; Beni B Wolf; Cesar Serrano; Erica K Evans; Ferry Eskens; Jonathan Trent; Margaret von Mehren; Maria Roche; Meera Tugnait; Michael C Heinrich; Olivier Mir; Patrick Schoffski; Philippe A Cassier; Piotr Rutkowski; Robin L Jones; Sant P Chawla; Sebastian Bauer; Suzanne George; Tamieka Lauz; Teresa Zhou; William D T
- Issued Date
- 2020
- Type
- Article
- Keyword
- Science & Technology; Life Sciences & Biomedicine; Oncology; PROGRESSION-FREE; TYROSINE KINASE; IMATINIB; MUTATIONS; MANAGEMENT; SURVIVAL; EFFICACY; MESYLATE; Aged; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors, Humans, Male, Middle Aged, Mutation, Prognosis, Pyrazoles, Pyrroles, Receptor, Platelet-Derived Growth Factor alpha, Triazines, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, 3211 Oncology and carcinogenesis
- DOI
- 10.1016/S1470-2045(20)30269-2
- URI
- https://oak.ulsan.ac.kr/handle/2021.oak/11964
- Publisher
- LANCET ONCOLOGY
- Language
- 영어
- ISSN
- 1470-2045
- Citation Volume
- 21
- Citation Number
- 7
- Citation Start Page
- 935
- Citation End Page
- 946
-
Appears in Collections:
- Medicine > Medicine
- Authorize & License
-
- Files in This Item:
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.